Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curasia Medilabs is an Indian healthcare company specializing in the development, manufacturing, and distribution of in-vitro diagnostic (IVD) products and medical laboratory equipment. Headquartered in New Delhi, the company offers an extensive portfolio of rapid diagnostic test kits for infectious diseases, including COVID-19, malaria, dengue, HIV, and hepatitis. Beyond rapid tests, Curasia Medilabs provides biochemistry reagents, hematology analyzers, and urine analysis strips designed for clinical laboratory use. The company focuses on delivering high-quality, cost-effective diagnostic solutions to healthcare providers and diagnostic centers. Their products are manufactured in compliance with international quality standards such as ISO and CE certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curasia Medilabs.